Ionis Pharmaceuticals (IONS) Leases (2021 - 2025)
Ionis Pharmaceuticals (IONS) has 7 years of Leases data on record, last reported at $242.0 million in Q3 2025.
- For Q3 2025, Leases rose 47.18% year-over-year to $242.0 million; the TTM value through Sep 2025 reached $242.0 million, up 47.18%, while the annual FY2024 figure was $161.9 million, 5.84% down from the prior year.
- Leases reached $242.0 million in Q3 2025 per IONS's latest filing, up from $163.9 million in the prior quarter.
- Across five years, Leases topped out at $242.0 million in Q3 2025 and bottomed at $18.0 million in Q4 2021.
- Average Leases over 5 years is $163.8 million, with a median of $169.4 million recorded in 2024.
- Peak YoY movement for Leases: soared 910.04% in 2022, then fell 6.0% in 2025.
- A 5-year view of Leases shows it stood at $18.0 million in 2021, then skyrocketed by 910.04% to $181.5 million in 2022, then fell by 5.31% to $171.9 million in 2023, then decreased by 5.84% to $161.9 million in 2024, then surged by 49.51% to $242.0 million in 2025.
- Per Business Quant database, its latest 3 readings for Leases were $242.0 million in Q3 2025, $163.9 million in Q2 2025, and $159.3 million in Q1 2025.